Castlebar, Ireland - October 27, 2017
Baxter Healthcare S.A.’s Castlebar and Swinford Manufacturing Plants in Ireland have been awarded the National Irish Safety Organisation’s (NISO) ‘Best Safety Program in the Manufacturing Sector‘ accolade in 2017. This Major Safety Award was presented to a team of representatives from Baxter at the annual Health and Safety Awards Presentation ceremony held in Galway on 13 October 2017.
In congratulating Baxter’s Irish Operations on this outstanding achievement, the adjudicating committee, consisting of a panel of experts in health and safety, including representatives from NISO and NISG (Northern Ireland Safety Group), commended Baxter for demonstrating a positive and proactive culture of safety management, combined with evidence of strong management leadership and continual improvement for superior performance.
Ciaran Geraghty, local Head of Operations with responsibility for Baxter manufacturing plants in Castlebar, Swinford and Liverpool said: “As part of a multinational organisation that prioritises the highest of safety standards in its global operations, this award is exceptional recognition for the progress of our local team’s journey towards a Zero Harm workplace. The Health and Safety of our employees and service providers in our workplace is an absolute key priority for us. I want to pay special tribute to all employees for their enthusiasm and commitment to their personal safety and to the safety of their colleagues and congratulate each one of them for their part in winning this accolade.
This award provides recognition of our Plants’ consistent approach to raising and implementing health and safety standards to the highest level. This success has been achieved through the efforts of our 1100 strong team across both sites led by our EHS group and our Senior Leadership team and with the help of our Regional and Corporate EHS&S partners building on every employee’s contributions.”
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anaesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.